published Jul 10th 2017, 5:18 pm, by Anna Edney (Bloomberg) —Congress must renew a fee program that funds government review of new drugs and medical devices, but a legislative logjam over the Senate’s health-care overhaul stands in its way. Lawmakers need to sign off on the drug and device fees

©2016 Bloomberg News O4VHJ1SYF022 (Bloomberg) — Heparin tainted with unauthorized Chinese- made ingredients may be on the market in the U.S. and the Food and Drug Administration hasn’t moved swiftly enough to prevent it, according to a congressional probe nearly a decade after hundreds of deaths were linked to sullied